Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Sun, Diabetes UK, Citeline News & Insights and The Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 90d ago.
Quick answers
Why is "Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Drug that delays type 1 diabetes approved for NHS The Telegraph · 90d ago
- Drug that delays onset of type 1 diabetes approved in England and Wales The Guardian · 90d ago
- Breakthrough in type 1 diabetes as drug offered on NHS delays start of disease The Sun · 90d ago
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS Diabetes UK · 90d ago
- England Leads Europe In Reimbursing Sanofi’s Type 1 Diabetes Disease-Modifying Therapy Tzield Citeline News & Insights · 90d ago
- Type 1 diabetes drug will delay onset by three years The Times · 90d ago
- Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS BBC · 90d ago
Topics
Related trends
Plan to limit NHS diagnoses of ADHD attacked as ‘rationing’ healthcare
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
On Israeli sanctions, Trump strikes an unusually restrained tone
The Trump administration has issued a rare muted response as the UK and European nations impose trade restrictions on Israeli West Bank settlements.
Got a migraine, acne or ear infection? Go to your chemist first
NHS expands the Pharmacy First scheme to allow chemists to treat conditions like migraines, acne and ear infections.
Prescribe exercise for prostate cancer patients, study says
New clinical evidence suggests supervised exercise programs can mitigate the side effects of prostate cancer treatments and improve patient quality of life.
Urine test can spot more than nine in 10 bladder cancers
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Doctors’ AI scribes get names of drugs and diagnoses wrong, NHS watchdog warns
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.